Maša Alečković

机构：Shaqra University · ORCID：0000-0001-5653-8502

发表论文 133 篇 · 总被引 7249 次 · h-index 22

代表论文

• Heterogeneity and transcriptional drivers of triple-negative breast cancer (2023 · Cell Reports · 被引 33)
• Development of a First-in-Class Click Chemistry–Based Cancer Therapeutic, from Preclinical Evaluation to a First-in-Human Dose Escalation Clinical Trial (2025 · Clinical Cancer Research · 被引 11)
• Phase 2a results of SQ3370, a doxorubicin-based click chemistry therapeutic in patients with advanced STS: Planned interim analysis. (2024 · Journal of Clinical Oncology · 被引 6)
• Abstract 1793: Pre-targeting with in vivo click chemistry enables preferential drug exposure in tumors versus normal tissues (2025 · Cancer Research · 被引 1)
• Abstract 342: First-in-class click chemistry-based pre-targeting of CEACAM5 tumor antigen selectively activates an MMAE payload at tumors (2025 · Cancer Research · 被引 1)
• Abstract 446: Pre-targeting with click chemistry facilitates selective MMAE activation in CEACAM5+ tumors: A first-in-class approach to enhance clinical benefit in targeted therapy. (2026 · Cancer Research)